Roger ChangAssociate Medical Director at ArrowheadSpeaker
Profile
Roger Chang is an Associate Medical Director and Clinical Development Lead for ARO-MAPT-SC at Arrowhead Pharmaceuticals. He completed his MD/PhD at UCSF, Neurology residency at the University of Washington, and Epilepsy fellowship at Stanford University, and is board certified in Neurology and Epilepsy. As a physician-scientist, Roger has experience in clinical development and translational neuroscience, with a focus on advancing therapies for neurodegenerative and other neurologic diseases.
Agenda Sessions
Clinical Progression of siRNA ARO-MAPT Phase 1/2a Study for Alzheimer’s Disease
, 11:20amView Session
